291 related articles for article (PubMed ID: 16503549)
21. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells.
Pession A; Martino V; Tonelli R; Beltramini C; Locatelli F; Biserni G; Franzoni M; Freccero F; Montemurro L; Pattacini L; Paolucci G
Oncogene; 2003 Nov; 22(54):8671-6. PubMed ID: 14647461
[TBL] [Abstract][Full Text] [Related]
22. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
23. Association of MLL amplification with poor outcome in acute myeloid leukemia.
Maitta RW; Cannizzaro LA; Ramesh KH
Cancer Genet Cytogenet; 2009 Jul; 192(1):40-3. PubMed ID: 19480936
[TBL] [Abstract][Full Text] [Related]
24. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloblastic leukaemia with alternations of MLL proto-oncogene protein (11q23/MLL+ AML)].
Mikulásová Z; Ilencíková D; Slamka T; Durovcíková D
Klin Onkol; 2010; 23(6):401-7. PubMed ID: 21351416
[TBL] [Abstract][Full Text] [Related]
26. MLL-MLLT10 fusion gene in pediatric acute megakaryoblastic leukemia.
Morerio C; Rapella A; Tassano E; Rosanda C; Panarello C
Leuk Res; 2005 Oct; 29(10):1223-6. PubMed ID: 16111539
[TBL] [Abstract][Full Text] [Related]
27. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).
Launay E; Henry C; Meyer C; Chappé C; Taque S; Boulland ML; Ben Abdelali R; Dugay F; Marschalek R; Bastard C; Fest T; Gandemer V; Belaud-Rotureau MA
Leuk Lymphoma; 2014 Mar; 55(3):662-7. PubMed ID: 23725386
[TBL] [Abstract][Full Text] [Related]
28. Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners.
Keefe JG; Sukov WR; Knudson RA; Nguyen LP; Williamson C; Sinnwell JP; Ketterling RP
J Mol Diagn; 2010 Jul; 12(4):441-52. PubMed ID: 20539022
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].
Huang S; Yang H; Gao L; Dou LP; Xu YY; Wang N; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1435-40. PubMed ID: 24370025
[TBL] [Abstract][Full Text] [Related]
30. Comparison of metaphase and interphase FISH monitoring of minimal residual disease with MLL gene probe: case study of AML with t(9;11).
Gallo JH; Robson LG; Watson NW; Sharma P; Smith A
Ann Genet; 1999; 42(2):109-12. PubMed ID: 10434126
[TBL] [Abstract][Full Text] [Related]
31. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T; Brady HJ
Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
[TBL] [Abstract][Full Text] [Related]
32. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.
Santos J; Cerveira N; Bizarro S; Ribeiro FR; Correia C; Torres L; Lisboa S; Vieira J; Mariz JM; Norton L; Snijder S; Mellink CH; Buijs A; Shih LY; Strehl S; Micci F; Heim S; Teixeira MR
Leuk Res; 2010 May; 34(5):615-21. PubMed ID: 19748670
[TBL] [Abstract][Full Text] [Related]
33. [Detection of rearrangements of mixed lineage leukemia gene and its clinical significance].
Chen WH; Chen CJ; Wang MC; Li CG; You WW; Huang RH; Li M; Tao XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):20-4. PubMed ID: 17490513
[TBL] [Abstract][Full Text] [Related]
34. Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene.
Saxe DF; Persons DL; Wolff DJ; Theil KS;
Arch Pathol Lab Med; 2012 Jan; 136(1):47-52. PubMed ID: 22208487
[TBL] [Abstract][Full Text] [Related]
35. A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.
Cerveira N; Meyer C; Santos J; Torres L; Lisboa S; Pinheiro M; Bizarro S; Correia C; Norton L; Marschalek R; Teixeira MR
BMC Cancer; 2010 Sep; 10():518. PubMed ID: 20920256
[TBL] [Abstract][Full Text] [Related]
36. A case of infantile acute lymphoblastic leukemia presenting with rearrangement of MLL at 11q23 and apparent insertion or translocation at 10p12.
Tirado CA; Lager J; Rosoff PM; Golembiski-Ruiz V; Gong JZ; Goodman BK
Cancer Genet Cytogenet; 2004 Oct; 154(1):57-9. PubMed ID: 15381373
[TBL] [Abstract][Full Text] [Related]
37. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
Srinivasan RS; de Erkenez AC; Hemenway CS
Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
[TBL] [Abstract][Full Text] [Related]
38. [Conventional cytogenetics and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in leukemia].
Liu XP; Li CW; Qin S; Dai Y; Xiao JG; Huang Q; Xu FY; Gong JY; Liu SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):798-803. PubMed ID: 16277845
[TBL] [Abstract][Full Text] [Related]
39. MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
Prange KHM; Mandoli A; Kuznetsova T; Wang SY; Sotoca AM; Marneth AE; van der Reijden BA; Stunnenberg HG; Martens JHA
Oncogene; 2017 Jun; 36(23):3346-3356. PubMed ID: 28114278
[TBL] [Abstract][Full Text] [Related]
40. [Application of reverse transcription-multiplex nested PCR to detect MLL rearrangement in AML-M4/M5].
Pan JL; Xue YQ; Jiang HY; He J; Wang W; Wu YF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):444-6. PubMed ID: 16086288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
